News Years after Pfizer merger, ex-Medivation exec gets insider t... A Medivation executive at the heart of the company's team that sold the company to Pfizer for $14 billion five years ago is facing allegations of insider trading.
Views & Analysis Why does UK biotech struggle to generate leaders? Can the UK emulate America's culture of biotech entrepreneurship?
News Takeda earmarks $15 billion for M&A - reports Japanese company could be on the acquisition trail.
News Merck, Pfizer and Gilead all interested in Medivation buy-ou... Sanofi has competition in its bid to acquire cancer specialist
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.